Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
Completed
NCT02944123
Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
120
Enrollment(s)
1
Study location(s)
Interventional (Phase III)
Acute Coronary Syndrome
Completed
NCT01951001
Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome
255
Enrollment(s)
1
Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
Platelet Thrombus
Bleeding
Completed
NCT00523744
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
257
Enrollment(s)
2
Study location(s)
Interventional (Phase III)
Hypertension
Completed
NCT04121767
Safety and Efficacy of Edoxaban in Thoracoscopic Ablation
60
Enrollment(s)
1
Study location(s)
Interventional (Not Applicable)
Atrial Fibrillation
Anticoagulants and Bleeding Disorders
Unknown status
NCT04072068
Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy
300
Enrollment(s)
18
Study location(s)
Interventional (Phase IV)
Thromboembolism
Cancer
Completed
NCT02234583
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
2,485
Enrollment(s)
0
Study location(s)
Interventional (Phase III)
Pain Associated With Fibromyalgia
Terminated
NCT02548611
Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention
795
Enrollment(s)
5
Study location(s)
Interventional (Phase IV)
Angina Pectoris
Withdrawn
NCT03027934
A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
0
Enrollment(s)
0
Study location(s)
Interventional (Phase IV)
Diabetes Mellitus
46
47
48
49
50